HK33584A - Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections - Google Patents

Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections

Info

Publication number
HK33584A
HK33584A HK335/84A HK33584A HK33584A HK 33584 A HK33584 A HK 33584A HK 335/84 A HK335/84 A HK 335/84A HK 33584 A HK33584 A HK 33584A HK 33584 A HK33584 A HK 33584A
Authority
HK
Hong Kong
Prior art keywords
formula
compound according
radical
meaning given
given above
Prior art date
Application number
HK335/84A
Other languages
German (de)
English (en)
French (fr)
Inventor
Ake John Erik Helgstrand
Karl Nils-Gunnar Johansson
Alfons Misiorny
Jan-Olof Noren
Goran Bertil Stening
Original Assignee
Astra Lakemedel Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel Aktiebolag filed Critical Astra Lakemedel Aktiebolag
Publication of HK33584A publication Critical patent/HK33584A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK335/84A 1977-12-22 1984-04-18 Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections HK33584A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB5358277 1977-12-22
GB5358377 1977-12-22
GB5358077 1977-12-22
GB5358177 1977-12-22
GB7828552 1978-07-03
GB7828553 1978-07-03
GB7828555 1978-07-03
GB7828548 1978-07-03

Publications (1)

Publication Number Publication Date
HK33584A true HK33584A (en) 1984-04-27

Family

ID=27571200

Family Applications (1)

Application Number Title Priority Date Filing Date
HK335/84A HK33584A (en) 1977-12-22 1984-04-18 Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections

Country Status (14)

Country Link
US (4) US4386081A (https=)
EP (2) EP0003275B1 (https=)
JP (2) JPS54109951A (https=)
AT (1) AT369017B (https=)
AU (1) AU530031B2 (https=)
CA (2) CA1144937A (https=)
DE (2) DE2861729D1 (https=)
DK (2) DK148632C (https=)
FI (2) FI65438C (https=)
HK (1) HK33584A (https=)
IE (1) IE48011B1 (https=)
MY (1) MY8500058A (https=)
NO (2) NO156611C (https=)
SG (1) SG82383G (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144937A (en) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5025003A (en) * 1989-09-18 1991-06-18 E. R. Squibb & Sons, Inc. Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5166386A (en) * 1989-09-18 1992-11-24 E. R. Squibb & Sons, Inc. Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5132414A (en) * 1990-05-10 1992-07-21 Dana-Farber Cancer Institute, Inc. Dideoxynucleoside-5'-phosphonoformic acid compounds
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US6096730A (en) * 1997-07-24 2000-08-01 University Of Kentucky Research Foundation Phosphonated agents and their antiangiogenic and antitumorigenic use
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
NZ550116A (en) * 1997-08-18 2008-03-28 Neurochem Int Ltd Phosphono-carboxylate compounds for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
WO1999040909A1 (en) * 1998-02-11 1999-08-19 Neurochem, Inc. Method for modulating macrophage activation
US6329356B1 (en) 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US6310073B1 (en) 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
CA2369997C (en) * 1999-04-28 2009-11-17 Queen's University At Kingston Compositions and methods for treating amyloidosis
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
IL150374A0 (en) 1999-12-23 2002-12-01 Neurochem Inc Compounds and methods for modulating cerebral amyloid angiopathy
ATE337309T1 (de) * 2002-04-01 2006-09-15 Pfizer Pyranon- und pyrandioninhibitoren der rna- abhängigen rna-polymerase des hepatitis-c-virus
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US20040214178A1 (en) * 2003-04-24 2004-10-28 Agouron Pharmaceuticals, Inc. Reporter-selectable Hepatitis C virus replicon
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
UA88909C2 (ru) * 2004-08-18 2009-12-10 Пфайзер Инк. Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с, фармацевтическая композиция на их основе и их применение
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
US20060167057A1 (en) * 2004-11-16 2006-07-27 Xianqi Kong Compounds for the treatment of CNS and amyloid associated diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1968561B8 (en) * 2005-12-22 2010-10-20 Kiacta Sàrl Treatment of diabetic nephropathy
PT2089417E (pt) 2006-10-12 2015-04-14 Bhi Ltd Partnership Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico
WO2008078176A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
DE102012103717A1 (de) * 2012-04-27 2013-11-14 Westfälische Wilhelms-Universität Münster Arzneimittel zur Behandlung von Tumorerkrankungen
WO2015093091A1 (ja) * 2013-12-19 2015-06-25 宇部興産株式会社 非水電解液、それを用いた蓄電デバイス、及びそれに用いられるホスホノぎ酸化合物
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
CN109400645A (zh) * 2017-08-18 2019-03-01 四川海思科制药有限公司 一种磷酸衍生物及制备方法和用途
WO2025106974A1 (en) * 2023-11-17 2025-05-22 The Board Of Trustees Of The Leland Stanford Junior University Prodrug moieties and compounds comprising the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155597A (en) * 1961-06-23 1964-11-03 Monsanto Co Extractive separation process
CH513590A (de) 1968-05-24 1971-10-15 Du Pont Carbamoylphosphonat enthaltender Pflanzenwachstumsregler
US3997544A (en) * 1968-05-24 1976-12-14 E. I. Du Pont De Nemours And Company Plant growth regulant carbamoylphosphonates
US3846512A (en) * 1968-05-24 1974-11-05 Du Pont Carbamoylphosphonates
US3533995A (en) * 1968-08-27 1970-10-13 Fmc Corp Heat stabilization of polyester resin with alkyl dialkoxyphosphinyl formate
GB1317768A (en) 1969-08-14 1973-05-23 Du Pont Plant growth regulants
US3849102A (en) * 1969-08-14 1974-11-19 Du Pont Plant growth regulant method
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
HU171255B (hu) 1973-07-23 1977-12-28 Du Pont Kompozicii dlja regulirovki rosta rastenijj
US3943201A (en) * 1973-07-23 1976-03-09 E. I. Du Pont De Nemours And Comapny Alkoxy carboxycarbonylphosphonic acid esters
US4017297A (en) * 1975-08-29 1977-04-12 E. I. Du Pont De Nemours And Company Phosphonates for the control of bindweed
US4092412A (en) * 1976-04-30 1978-05-30 Abbott Laboratories Treatment of herpes simplex infections
CA1069526A (en) * 1976-04-30 1980-01-08 Thomas R. Herrin Phosphorus esters of phosphonoacetic acid
US4052439A (en) * 1976-04-30 1977-10-04 Abbott Laboratories Carboxylic esters of phosphonoacetic acid
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
CA1144937A (en) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections

Also Published As

Publication number Publication date
JPS6330885B2 (https=) 1988-06-21
DK564178A (da) 1979-06-23
EP0003275B1 (en) 1981-09-02
DK564278A (da) 1979-06-23
DK148631C (da) 1986-03-03
FI68626C (fi) 1985-10-10
JPS6254118B2 (https=) 1987-11-13
DE2861729D1 (en) 1982-05-19
EP0003007A3 (en) 1979-08-08
US4591583A (en) 1986-05-27
NO784331L (no) 1979-06-25
NO154751B (no) 1986-09-08
JPS54109951A (en) 1979-08-29
NO784330L (no) 1979-06-25
DK148632B (da) 1985-08-19
IE782493L (en) 1979-06-22
NO156611C (no) 1987-10-21
NO154751C (no) 1986-12-17
DK148631B (da) 1985-08-19
NO156611B (no) 1987-07-13
FI783932A7 (fi) 1979-06-23
FI68626B (fi) 1985-06-28
FI65438C (fi) 1984-05-10
DE2861045D1 (en) 1981-11-26
IE48011B1 (en) 1984-09-05
DK148632C (da) 1986-03-03
US4386081A (en) 1983-05-31
SG82383G (en) 1985-03-08
FI783931A7 (fi) 1979-06-23
FI65438B (fi) 1984-01-31
AT369017B (de) 1982-11-25
CA1144937A (en) 1983-04-19
JPS54106431A (en) 1979-08-21
AU4268278A (en) 1979-06-28
EP0003007B1 (en) 1982-04-07
CA1140049A (en) 1983-01-25
AU530031B2 (en) 1983-06-30
US4372894A (en) 1983-02-08
MY8500058A (en) 1985-12-31
EP0003275A1 (en) 1979-08-08
ATA921778A (de) 1982-04-15
US4536400A (en) 1985-08-20
EP0003007A2 (en) 1979-07-11

Similar Documents

Publication Publication Date Title
EP0003275B1 (en) Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections
AU700651B2 (en) Improved antiviral prodrugs
EP0074306B1 (en) Anti-viral guanine derivatives
US4665062A (en) Method for combating virus infection
JP2002511406A (ja) 感染症の治療および予防処置のための有機リン化合物の使用
NZ222553A (en) Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
EA008775B1 (ru) Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция
EP0165164A1 (en) Anti-viral compounds, their preparation and anti-viral compositions
TW201751B (https=)
US5227508A (en) 3-deoxy-3-substituted analogs of phosphatidylinositol
EP0003008A1 (en) Amide derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
GB2122198A (en) Antiviral guanine derivatives
MXPA01006456A (es) Compuestos organicos de fosforo y su uso.
CA1156651A (en) Derivatives of hydroxycarbonylphosphonic acid
EP0145739B1 (en) Novel antiviral agents
US7420000B2 (en) Amino phosphonate and amino bis-phosphonate derivatives
IE47694B1 (en) Aromatic derivatives of phosphonoformic acid,processes for their preparation,pharmaceutical compositions containing them and their use for combating virus infections
KR840002463B1 (ko) 방향족 포스포노 포름산 모노에스테르의 제조방법
CA1108176A (en) Arylalkyl and aryloxyalkyl phosphonates and preparation thereof
RU2126413C1 (ru) Производные фосфолипидов, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
KR840002464B1 (ko) 지방족 포스포노포름산 모노에스테르의 제조방법
HUP0001524A2 (hu) Kovalens foszfolipid-foszfonokarbonsav-konjugátumok és ezeket tartalmazó gyógyszerkészítmények
Wyrick et al. Tritium Labelled 1‐O‐Octadecyl‐2‐O‐methyl‐rac‐glycero‐3‐phosphocholine (ALP) and 1‐S‐Hexadecyl‐2‐O‐ethyl‐rac‐thioglycero‐3‐phosphocholine (Thio‐ALP)
AT369016B (de) Verfahren zur herstellung neuer hydroxycarbonyl- phosphonsaeurederivate sowie von deren physiologisch akzeptablen salzen und optischen antipoden

Legal Events

Date Code Title Description
PE Patent expired